Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 05.10.2026 3 Am J Manag Care 1 Am J Ophthalmol 1 Biochem Biophys Res Commun 3 BMC Ophthalmol 1 Diabet Med 4 Diabetes 5 Diabetes Care 16 Diabetes Obes Metab 15 Diabetologia 3 Invest Ophthalmol Vis Sci 1 J Am Soc Nephrol 1 J Clin Endocrinol Metab 1 J Immunol 2 Lancet 1 Med Care 1 Metabolism 1 N Engl J Med 1 Obstet Gynecol 2 Ophthalmol Retina 9 Pediatr Diabetes 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Manag Care

1. DAMACHI U, Okoye G, Camelo Castillo W, dosReis S, et al
   SGLT2 Inhibitor Adherence and Diabetes Hospitalization Risk in Type 2 Diabetes.
   Am J Manag Care. 2026;32:492-499.
   PubMed         Abstract available
   
   
2. PARIKH MA, Nsiah I, Ramachandran S, Campbell PJ, et al
   The Association Between Patient Out-of-Pocket Medical Costs and Medication Adherence.
   Am J Manag Care. 2026;32:510-514.
   PubMed         Abstract available
   
   
3. SUZUKI H, Vaughan-Sarrazin M, Ohl M, Mecham B, et al
   Community Care Consultations for Veterans with Diabetic Foot Ulcers.
   Am J Manag Care. 2026;32:e309-e315.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

4. KIM SB, Zhou MY, Allan KC, Kaelber DC, et al
   Corrigendum to "Evaluation of the Impact of Gamma-Aminobutyric Acid on Diabetic Retinopathy in a Large US Population-Based Cohort". Am J Ophthalmol. 2026;291:63-72.
   Am J Ophthalmol. 2026 Oct 1:S0002-9394(26)00527.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

5. MASOUDI FS, Salehizade Y, Daryanoosh F, Jahromi MK, et al
   Combined exercise training and resveratrol supplementation modulate diabetes-related factors and mitochondrial biogenesis in male diabetic rats exposed to acute acoustic stress.
   Biochem Biophys Res Commun. 2026;838:154635.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

6. BIRGUL R, Cetin M
   Comparison of retinal thickness and choroidal vascularity index after vitrectomy in idiopathic versus diabetic epiretinal membrane.
   BMC Ophthalmol. 2026;26:611.
   PubMed         Abstract available
   
   
7. SARITAS O, Sahin E, Tasci YY, Toklu Y, et al
   Preoperative OCT biomarkers and surgical outcomes after vitrectomy with epiretinal membrane and internal limiting membrane peeling for refractory diabetic macular edema: a retrospective cohort study.
   BMC Ophthalmol. 2026;26:598.
   PubMed         Abstract available
   
   
8. DONG X, Okuwobi IP
   Dual-decoder multi-task network with graph attention mechanism for OCT retinal layer and fluid segmentation.
   BMC Ophthalmol. 2026 Jul 4. doi: 10.1186/s12886-026-05081.
   PubMed         Abstract available
   
   

   
   Diabet Med

9. HABTE-ASRES HH, Afuwape S, Heald A, Wheeler DC, et al
   Association between depression and the development of end-stage kidney disease in people with diabetes: A population-based cohort study.
   Diabet Med. 2026 Sep 30:e70481. doi: 10.1111/dme.70481.
   PubMed         Abstract available
   
   

   
   Diabetes

10. SCALA R, Zhang H, Gao J, Nichols CG, et al
    Multiple ABCC8 Loss-of-Function Mutations Associated with Paradoxical Maturity-Onset Diabetes of the Young.
    Diabetes. 2026 Oct 1:db260406. doi: 10.2337/db26-0406.
    PubMed         Abstract available
    
    
11. KHURANA I, Hansen TW, Persson F, Birkelund S, et al
    Blood-Derived DNA Methylation Biomarkers Predict Diabetic Kidney Disease and Map to Epigenomic Remodeling in Renal Cells.
    Diabetes. 2026 Oct 1:db260015. doi: 10.2337/db26-0015.
    PubMed         Abstract available
    
    
12. JI R, Yang Q, Hu H
    Nutrient-Sensitive Senescence Checkpoints in Diabetic Kidney Disease.
    Diabetes. 2026 Sep 28:db260464. doi: 10.2337/db26-0464.
    PubMed         Abstract available
    
    
13. GASTALDELLI A, Choi E, Conde-Knape K, Goransson O, et al
    Insulin Resistance in the 21st Century: New Takes on an Old Problem-2025 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetes. 2026 Sep 28:dbi260044. doi: 10.2337/dbi26-0044.
    PubMed         Abstract available
    
    

    
    Diabetes Care

14. DAVIES MJ, Aroda VR, Bajaj M, ElSayed NA, et al
    Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetes Care. 2026 Oct 2:dci260141. doi: 10.2337/dci26-0141.
    PubMed         Abstract available
    
    
15. SLACK SD, Venkatesh N, Ridoux SE, Hohsfield KR, et al
    Genetic Susceptibility in Relative Maternal Protection From Type 1 Diabetes.
    Diabetes Care. 2026 Oct 1:dc261524. doi: 10.2337/dc26-1524.
    PubMed         Abstract available
    
    
16. MARTIN CL, Bott M, Herman WH, Braffett BH, et al
    Increased Risk of Obstructive Sleep Apnea and Poor Sleep Quality Among Older Adults With Type 1 Diabetes: The DCCT/EDIC Study.
    Diabetes Care. 2026 Sep 29:dc261678. doi: 10.2337/dc26-1678.
    PubMed         Abstract available
    
    
17. FERM ML, Huang X, Minard CG, DeSalvo DJ, et al
    Insulin Dose-Adjusted Hemoglobin A1c Has Suboptimal Performance for Identifying C-Peptide-Defined Partial Remission: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2026 Sep 29:dc261313. doi: 10.2337/dc26-1313.
    PubMed         Abstract available
    
    
18. GASTALDELLI A, Choi E, Conde-Knape K, Goransson O, et al
    Insulin Resistance in the 21st Century: New Takes on an Old Problem-2025 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetes Care. 2026 Sep 28:dci260142. doi: 10.2337/dci26-0142.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

19. COSSON E, Aguayo G, Crequer-Grandhomme A, Bahloul A, et al
    Prevalence of Chronic Complications After Inaugural Admission in Intensive Care Unit for Type 1 Diabetes in the SFDT1 Cohort: The INAUGURAL Study.
    Diabetes Obes Metab. 2026 Oct 2. doi: 10.1111/dom.71393.
    PubMed         Abstract available
    
    
20. LI Y, Zhang F, Liu W, Su X, et al
    Efficacy and Safety of Crisugabalin for Inadequately Controlled Diabetic Peripheral Neuropathic Pain: A Randomized, Active-Controlled, Phase 2 Trial.
    Diabetes Obes Metab. 2026 Oct 2. doi: 10.1111/dom.71401.
    PubMed         Abstract available
    
    
21. FOTROS D, Sakhdari H, Shin AC
    Metformin Use Is Associated With Better Cognitive Performance in Older Adults With Type 2 Diabetes: Exploratory Analysis of Vitamin B12 and Methylmalonic Acid Pathways in NHANES 2011-2014.
    Diabetes Obes Metab. 2026 Sep 28. doi: 10.1111/dom.71396.
    PubMed         Abstract available
    
    
22. SHI H, Zhai X, Zhu P, Wang B, et al
    Risk Stratification by eGFR < 45 mL/min/1.73 m(2) for All-Cause Mortality in Patients With Diabetic Foot Ulcer: A Multidisciplinary Retrospective Cohort Study.
    Diabetes Obes Metab. 2026 Sep 27. doi: 10.1111/dom.71365.
    PubMed         Abstract available
    
    
23. 
    Addendum to "The Duodenal Mucosa Plays a Key Role in Metabolic Regulation: Emerging Physiology and New Opportunities for Cell-Directed and Barrier-Related Interventions for the Treatment of Diabetes and Obesity".
    Diabetes Obes Metab. 2026 Sep 27. doi: 10.1111/dom.71379.
    PubMed        
    
    
24. KANG HY, Han K, Yoon DH, Choi SY, et al
    Body Weight Change and Dementia Risk in Young and Middle-Aged Adults With Type 2 Diabetes and Depression: A Nationwide Cohort Study.
    Diabetes Obes Metab. 2026 Sep 27. doi: 10.1111/dom.71388.
    PubMed         Abstract available
    
    
25. LIU Y, Chen Y, Chen Y, Jian X, et al
    Accuracy and Safety of the LinX Continuous Glucose Monitoring System in Adults With Diabetes: A Prospective Multicentre Open-Label Clinical Performance Study.
    Diabetes Obes Metab. 2026 Oct 1. doi: 10.1111/dom.71392.
    PubMed         Abstract available
    
    
26. HAMILTON A, Thisted L, Ougaard M, Hahn M, et al
    Nephroprotective Effects of the Dual GCGR/GLP-1R Agonist Survodutide in Hypertension-Accelerated Diabetic Kidney Disease.
    Diabetes Obes Metab. 2026 Oct 1. doi: 10.1111/dom.71387.
    PubMed         Abstract available
    
    
27. WANG X, Jiao M, Ma W
    Effects of a Low-Carbohydrate Diet Combined With Exercise on HbA1c in Adults With Type 2 Diabetes: A Bayesian Multilevel Network and Dose-Response Meta-Analysis.
    Diabetes Obes Metab. 2026 Sep 30. doi: 10.1111/dom.71406.
    PubMed         Abstract available
    
    
28. FANG Q, Peng J, Fan G, Li J, et al
    Sleep Patterns During Pregnancy, Genetic Susceptibility and Progression From Gestational Diabetes Mellitus to Postpartum Glucose Intolerance: A Prospective Cohort Study.
    Diabetes Obes Metab. 2026 Sep 30. doi: 10.1111/dom.71376.
    PubMed         Abstract available
    
    
29. XU H, Ma M, Jia Z, Cuan S, et al
    Immune Mechanisms and Translational Therapeutic Challenges in Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Sep 30. doi: 10.1111/dom.71409.
    PubMed         Abstract available
    
    
30. CAVALCANTE LIMA CHAGAS G, Rios Leite Macedo Monteiro M, Eira ML, Chiappa GR, et al
    Contemporary Initial Glucose-Lowering Strategies for Type 2 Diabetes: A Systematic Review and Bayesian Network Meta-Analysis.
    Diabetes Obes Metab. 2026 Sep 29. doi: 10.1111/dom.71397.
    PubMed         Abstract available
    
    
31. LI K, Xu L, Shi S, Jiang X, et al
    Carbohydrate Intake Variability, Weight Change and Type 2 Diabetes Risk: A Prospective Cohort Study.
    Diabetes Obes Metab. 2026 Sep 29. doi: 10.1111/dom.71389.
    PubMed         Abstract available
    
    
32. RIVELINE JP, Potier L, Levrat-Guillen F, Chesters C, et al
    Real-World Burden of Diabetic Ketoacidosis in Type 1 Diabetes in the French SFDT1 Cohort: The SFDT1-DKA Study.
    Diabetes Obes Metab. 2026 Sep 28. doi: 10.1111/dom.71383.
    PubMed         Abstract available
    
    
33. BAI H, Yu J, Zhu Q, Zhou X, et al
    Genotype-Dependent Functional and Pharmacological Profiling of Rare GCK Variants Reveals Implications for Precision Management of Monogenic Diabetes.
    Diabetes Obes Metab. 2026 Sep 28. doi: 10.1111/dom.71398.
    PubMed         Abstract available
    
    
34. YANG R, Cho K, Petersen MC, Jones KE, et al
    Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis.
    Diabetes Obes Metab. 2026 Sep 28. doi: 10.1111/dom.71390.
    PubMed         Abstract available
    
    

    
    Diabetologia

35. DAVIES MJ, Aroda VR, Bajaj M, ElSayed NA, et al
    Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2026 Oct 2. doi: 10.1007/s00125-026-06855.
    PubMed         Abstract available
    
    
36. MORI T, Cardoso P, Dennis JM, Kuss O, et al
    Type 2 diabetes subtypes, aetiology and pathophysiology. Reply to Vaag A [letter].
    Diabetologia. 2026 Sep 30. doi: 10.1007/s00125-026-06888.
    PubMed        
    
    
37. FRECKMANN G, Konig IR, Grube H, Vens M, et al
    Efficacy of the digital therapeutic glucura combined with CGM in the treatment of type 2 diabetes: a randomised controlled trial over 6 months.
    Diabetologia. 2026 Oct 1. doi: 10.1007/s00125-026-06880.
    PubMed         Abstract available
    
    
38. VAAG A
    Type 2 diabetes subtypes, aetiology and pathophysiology.
    Diabetologia. 2026 Oct 1. doi: 10.1007/s00125-026-06887.
    PubMed        
    
    
39. SCARAMUZZA AE, Marigliano M
    Choosing diabetes technology in children and adolescents: beyond preference to fit.
    Diabetologia. 2026 Sep 30. doi: 10.1007/s00125-026-06881.
    PubMed        
    
    
40. HOLT RIG, DeVries JH, Hess-Fischl A, Hirsch IB, et al
    Correction: The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2026 Sep 30. doi: 10.1007/s00125-026-06893.
    PubMed        
    
    
41. KIM S, Ko HY, Hong B, Kim JH, et al
    Comparative hepatic effectiveness of empagliflozin vs dapagliflozin among individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.
    Diabetologia. 2026 Sep 30. doi: 10.1007/s00125-026-06870.
    PubMed         Abstract available
    
    
42. COLLIER M, Chouchana L, Kaguelidou F, Treluyer JM, et al
    Safety of glucagon-like peptide-1 receptor agonists and other new-generation glucose-lowering agents for the management of type 2 diabetes in pregnancy: a French nationwide population-based study.
    Diabetologia. 2026 Sep 29. doi: 10.1007/s00125-026-06882.
    PubMed         Abstract available
    
    
43. SAMUELSSON H, Hojjati S, Teixeira P, Lindqvist A, et al
    Delayed time to stage 3 type 1 diabetes after GAD-alum treatment in HLA-DR3-DQ2-positive children: follow-up of the randomised placebo-controlled Diabetes Prevention - Immune Tolerance trial.
    Diabetologia. 2026 Sep 28. doi: 10.1007/s00125-026-06875.
    PubMed         Abstract available
    
    
44. GASTALDELLI A, Choi E, Conde-Knape K, Goransson O, et al
    Insulin resistance in the 21st century: new takes on an old problem-2025 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2026 Sep 28. doi: 10.1007/s00125-026-06853.
    PubMed         Abstract available
    
    
45. DE KAM SS, Reed T, Rutters F, Campbell DJT, et al
    The impact of physical activity and exercise timing on metabolic health among individuals at high risk of type 2 diabetes.
    Diabetologia. 2026 Sep 26. doi: 10.1007/s00125-026-06871.
    PubMed         Abstract available
    
    
46. QIU S, Xie D, Guo S, Wang Z, et al
    Metformin protects podocytes by inhibiting the MAPK14-SLC7A11-GPX4 axis and dysregulation of fatty acid metabolism.
    Diabetologia. 2026;69:3312-3327.
    PubMed         Abstract available
    
    
47. STEFAN N, Targher G
    Pharmacological treatment of MASH.
    Diabetologia. 2026;69:3148-3161.
    PubMed         Abstract available
    
    
48. WILD SH, Lazarus JV, Spearman CW, Ocama P, et al
    MASLD prevalence, incidence and global aspects.
    Diabetologia. 2026;69:3034-3047.
    PubMed         Abstract available
    
    
49. SEGEV N, Mouzaki M
    Updates on paediatric MASLD: insights from an endocrine lens.
    Diabetologia. 2026;69:3121-3130.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

50. SUN H, Zhou L, Luo T, Li C, et al
    L-Threonic Acid Inhibits Pathological Retinal Neovascularization by Modulation of CCL3-CCR5 Signaling Pathway.
    Invest Ophthalmol Vis Sci. 2026;67:51.
    PubMed         Abstract available
    
    
51. LIU X, Lin H, Shao Y, Shen J, et al
    Study on the Regulatory Mechanism of GLP-1 Receptor Agonist Liraglutide in Diabetic Corneal Epithelial Wound Healing.
    Invest Ophthalmol Vis Sci. 2026;67:52.
    PubMed         Abstract available
    
    
52. OWUSU-AFRIYIE B, Wu CS, Kafle R, Burhans L, et al
    Multimodal Retinal Structural and Functional Tests Identify Local and Layer-Related Alterations in Early Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2026;67:3.
    PubMed         Abstract available
    
    

    
    J Am Soc Nephrol

53. MOEDT E, Koshino A, Jongs N, Ju W, et al
    Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition.
    J Am Soc Nephrol. 2026;37:2210-2220.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

54. OKTAVIAN P, Kencono Wungu CD, Amin IM, Mudjanarko SW, et al
    Glycemic and psychosocial outcomes of automated insulin delivery in older and high-risk populations with type 1 diabetes: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2026 Sep 30:dgag344. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Immunol

55. YOU T, Yang H, Chen G
    Mechanism of SGLT2 inhibitors in improving immune imbalance in diabetic mice with sepsis via regulating macrophage M2 polarization through the APOC1/HMGB1/TLR4 axis.
    J Immunol. 2026;215:vkag240.
    PubMed         Abstract available
    
    

    
    Lancet

56. BELLIDO V, le Roux CW, Ekinci EI, Bjornstad P, et al
    Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.
    Lancet. 2026 Sep 29:S0140-6736(26)01861-1. doi: 10.1016/S0140-6736(26)01861.
    PubMed         Abstract available
    
    
57. KLEIN KR, Wysham C, Tuttle KR, Davies MJ, et al
    Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.
    Lancet. 2026 Sep 30:S0140-6736(26)01865-9. doi: 10.1016/S0140-6736(26)01865.
    PubMed         Abstract available
    
    

    
    Med Care

58. THOMPSON KD, Sabharwal M, Lasser KE, McCloskey L, et al
    Postpartum Linkage to Primary Care Among Patients With Diabetes and Hypertensive Disorders of Pregnancy Following Medicaid ACO Implementation.
    Med Care. 2026 Oct 1. doi: 10.1097/MLR.0000000000002389.
    PubMed         Abstract available
    
    

    
    Metabolism

59. ZENG Y, Hu H, Rong R, Liu J, et al
    Association of severe liver disease and diabetic retinopathy, retinal imaging phenotypes, and plasma metabolic signatures: A UK biobank study.
    Metabolism. 2026 Oct 2:156772. doi: 10.1016/j.metabol.2026.156772.
    PubMed         Abstract available
    
    

    
    N Engl J Med

60. WHARTON S, le Roux CW, Startseva E, Kloer IM, et al
    Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes.
    N Engl J Med. 2026 Oct 1. doi: 10.1056/NEJMoa2607219.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

61. YUN BH, Seo SK, Maher JY, Dowlut-McElroy T, et al
    Prepregnancy Insulin Resistance and Fertility and Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome.
    Obstet Gynecol. 2026 May 22. doi: 10.1097/AOG.0000000000006318.
    PubMed         Abstract available
    
    

    
    Ophthalmol Retina

62. HALLAJ S, Nishida T, Kamalipour A, Longhurst CA, et al
    Glucagon Like Peptide 1 Receptor Agonists and Age-Related Macular Degeneration Incidence.
    Ophthalmol Retina. 2026 Jun 1:S2468-6530(26)00266.
    PubMed         Abstract available
    
    
63. BUTT FR, Al-Burak SA, Abid F, Shad J, et al
    Anti-Vascular Endothelial Growth Factor Injection-to-Surgery Interval in Diabetic Vitrectomy: A Systematic Review and Meta-Analysis.
    Ophthalmol Retina. 2026 Sep 28:S2468-6530(26)00499.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

64. CROSSEN S, Lopez S, Lewis C, Tancredi D, et al
    A randomized trial comparing supplemental video care and asynchronous remote monitoring among young people with type 1 diabetes and elevated glycemic levels.
    Pediatr Diabetes. 2026;2026:e007.
    PubMed         Abstract available
    
    
65. BOOIJINK RS, de Haan JS, Van Den Berg L, Jansen TJP, et al
    Bihormonal fully closed-loop glucose control in adolescents with Type 1 diabetes: an outpatient, randomized, crossover trial.
    Pediatr Diabetes. 2026;2026:e008.
    PubMed         Abstract available
    
    
66. ZHANG T, Wang N, Wang B, Wang M, et al
    Efficacy and safety of hybrid closed-loop systems in children aged < 7 years with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials.
    Pediatr Diabetes. 2026;2026:e006.
    PubMed         Abstract available
    
    
67. HEJLA D, Hawke K, Borovoi L, Elliott T, et al
    Open-source automated insulin delivery shows comparable glycemic outcomes to a commercial hybrid closed-loop system in real-world type 1 pediatric diabetes care: a retrospective cohort study from British Columbia, Canada.
    Pediatr Diabetes. 2026;2026:e009.
    PubMed         Abstract available
    
    
68. UNSAL Y, Sancak E, Celik Ertas NB, Langley DB, et al
    Severe onset type 1 diabetes mellitus with unusual manifestations due to CD70 deficiency: novel pathway in deciphering the etiopathogenesis of type 1 diabetes mellitus, and the experience with hematopoietic stem cell transplantation.
    Pediatr Diabetes. 2026;2026:e003.
    PubMed         Abstract available
    
    
69. ZHANG K, Kan C, Han F, Li X, et al
    Diverging regional inequalities in childhood diabetes, 1990-2023: a GBD 2023-based analysis.
    Pediatr Diabetes. 2026;2026:e001.
    PubMed         Abstract available
    
    
70. RAM S, Corbin M, Eng A, Kvalsvig A, et al
    Early life antibiotic-use and risk of childhood type 1 diabetes: a nationwide cohort study utilising data linkage.
    Pediatr Diabetes. 2026;2026:e004.
    PubMed         Abstract available
    
    
71. MARCH CA, Naame E, Alfinito S, Rankine J, et al
    Barriers and facilitators to the implementation of school-partnered collaborative type 1 diabetes interventions: a qualitative comparative analysis with school nurses to guide implementation.
    Pediatr Diabetes. 2026;2026:e002.
    PubMed         Abstract available
    
    
72. SCHNAPPER M, Guz-Mark A, Matar M, Phillip M, et al
    Celiac disease and celiac serology in children with Type 1 Diabetes: diagnostic timing, serologic patterns, and implications for long-term management.
    Pediatr Diabetes. 2026;2026:e005.
    PubMed         Abstract available
    
    

    
    PLoS One

73. LOTFY M, Al Sawai F, Alyammahi D, Kundu B, et al
    Metformin modulates survival, oxidative stress, and gene expression in a high-sucrose Drosophila diabetes model.
    PLoS One. 2026;21:e0359638.
    PubMed         Abstract available
    
    
74. HORMENU T, Antiri EO, Awlime-Ableh E, Paku JE, et al
    Prevalence and risk factors of cardiometabolic disease among informal sector workers in Cape Coast, Ghana: Insights from the CarMeR study.
    PLoS One. 2026;21:e0359530.
    PubMed         Abstract available
    
    
75. LAM QA, Phan HH, Le LHG, Do MD, et al
    Association of IL16 rs11556218 and IL1B rs16944 polymorphisms with type 2 diabetes in the Kinh Vietnamese population.
    PLoS One. 2026;21:e0358570.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum